Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125643863 | 12564386 | 3 | F | 20160512 | 20160915 | 20160718 | 20160921 | EXP | EC-ROCHE-1795025 | ROCHE | 28.97 | YR | M | Y | 0.00000 | 20160921 | CN | EC | EC |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125643863 | 12564386 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | SOLUTION FOR INFUSION | /month | ||||||||
| 125643863 | 12564386 | 2 | SS | MABTHERA | RITUXIMAB | 1 | U | 103705 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125643863 | 12564386 | 1 | Leukaemia |
| 125643863 | 12564386 | 2 | Non-Hodgkin's lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125643863 | 12564386 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125643863 | 12564386 | Bacterial infection | |
| 125643863 | 12564386 | Decreased immune responsiveness | |
| 125643863 | 12564386 | Gait disturbance | |
| 125643863 | 12564386 | Infection | |
| 125643863 | 12564386 | Leukaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125643863 | 12564386 | 1 | 20151106 | 0 |